Everest Clinical acquires August Research for undisclosed price
08 Nov 2023
Acquisition
Preview
Source: FierceBiotech
In a move to expand its footprint in Europe, Canadian CRO Everest Clinical acquired Bulgaria-based August Research.
Everest Clinical, a portfolio company of Arlington Capital Partners, picked up Bulgaria-based August Research, giving the Canadian CRO a presence in Europe.
August Research has experience and infrastructure in 14 countries in Western and Eastern Europe. Through the deal, Everest will be able to provide clinical trial services (CTS) offerings and other operational capabilities to its clients, including pharma, biotech and medical device companies, in Europe, the company said in a Nov. 7 press release.
Financial details of the deal weren’t disclosed.
Dana Leff Niedzielska and Lukasz Niedzielski, August’s founders, as well as managing directors in the company’s European offices, will remain with the combined companies, Everest said.
“The acquisition of August is highly strategic for Everest as it further expands our global service offering and establishes a beachhead in one of the largest clinical trial markets in the world,” Malcolm Little, a partner at Arlington Capital, said in the release. “With the addition of several European offices to complement Everest’s existing presence in North America and Asia, Everest further engrains itself as a truly global CRO.”
Everest’s deal bucks the recent trend of Canadian CROs being the target of acquisitions versus the pursuer. In recent months, Canadian CROs Cirion Biopharma, Nucro-Technics and NuChem Sciences were snapped up in acquisition deals.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.